Antoine is a senior partner at Truffle Capital. Pior to joining Truffle Capital, Antoine had experiences at Novartis Pharma (oncology business unit) and Mazars (audit and transaction services). His expertise and track record cover the creation, structuration and financing of healthcare companies from early R&D to commercial stage, IPO or trade sale. Antoine is a board member of BariaTek Medical (clinical-stage endoscopic implant to treat obesity) as well as Skinosive (long-acting UV filters for better sun protection). He was previously the CEO of SpikImm, founded by Truffle Capital and the Institut Pasteur to develop mAbs to prevent viral diseases in immunocompromised patients. Pharmacist and graduated from the ESSEC Business School (Master in Management), Antoine is a guest lecturer at Sorbonne University, ESSEC, as well as a regular jury member at X-HEC Entrepreneurs.